[Efficacy and Safety of Flumatinib in Treatment of Patients with Chronic Myeloid Leukemia].

Zhang, Qian; Qi, Ling; Ji, De-Xiang; Li, Fei

Zhang, Qian; Qi, Ling; Ji, De-Xiang; Li, Fei.

Affiliation

Zhang Q; Department of Hematology, The First Affiliated Hospital of Nanchang University; Institute of Hematology, Academy of Clinical Medicine of Jiangxi Province, Nanchang 330006, Jiangxi Province, China.
Qi L; Department of Hematology, The First Affiliated Hospital of Nanchang University; Institute of Hematology, Academy of Clinical Medicine of Jiangxi Province, Nanchang 330006, Jiangxi Province, China.
Ji DX; Department of Hematology, The First Affiliated Hospital of Nanchang University; Institute of Hematology, Academy of Clinical Medicine of Jiangxi Province, Nanchang 330006, Jiangxi Province, China.
Li F; Department of Hematology, The First Affiliated Hospital of Nanchang University; Institute of Hematology, Academy of Clinical Medicine of Jiangxi Province, Nanchang 330006, Jiangxi Province, China. E-mail: yx021021@sina.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 31(4): 1014-1018, 2023 Aug.

Article de Zh | MEDLINE | ID: mdl-37551470

Sujet(s)
Mots clés

chronic meyloid leukemia; efficacy; flumatinib; safety

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie myéloïde chronique BCR-ABL positive / Antinéoplasiques Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Langue: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Sujet du journal: HEMATOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google